| Product Code: ETC12192322 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Belgium continues to rely on major exporters like the USA, Austria, Netherlands, Hungary, and the UK for its follicle-stimulating hormone imports in 2024. Despite a significant decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) over the period of 2020-24 remains impressive at 39.8%. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), stayed high in 2024. This data suggests a stable demand for follicle-stimulating hormone in Belgium with strong ties to key exporting countries.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Follicle-Stimulating Hormone Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, 2022 & 2032F |
3.3 Belgium Follicle-Stimulating Hormone Market - Industry Life Cycle |
3.4 Belgium Follicle-Stimulating Hormone Market - Porter's Five Forces |
3.5 Belgium Follicle-Stimulating Hormone Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Belgium Follicle-Stimulating Hormone Market Revenues & Volume Share, By Form, 2022 & 2032F |
3.7 Belgium Follicle-Stimulating Hormone Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Belgium Follicle-Stimulating Hormone Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Belgium Follicle-Stimulating Hormone Market Revenues & Volume Share, By Dosage, 2022 & 2032F |
4 Belgium Follicle-Stimulating Hormone Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infertility issues in Belgium |
4.2.2 Growing awareness about fertility treatments and assisted reproductive technologies |
4.2.3 Technological advancements in the field of reproductive medicine |
4.3 Market Restraints |
4.3.1 High cost associated with follicle-stimulating hormone treatments |
4.3.2 Stringent regulations and approvals required for fertility drugs in Belgium |
4.3.3 Limited reimbursement policies for fertility treatments |
5 Belgium Follicle-Stimulating Hormone Market Trends |
6 Belgium Follicle-Stimulating Hormone Market, By Types |
6.1 Belgium Follicle-Stimulating Hormone Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Recombinant FSH, 2022 - 2032F |
6.1.4 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Urinary-Derived FSH, 2022 - 2032F |
6.1.5 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Human FSH, 2022 - 2032F |
6.1.6 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Synthetic FSH, 2022 - 2032F |
6.2 Belgium Follicle-Stimulating Hormone Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Injection, 2022 - 2032F |
6.2.3 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Powder, 2022 - 2032F |
6.2.4 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Liquid, 2022 - 2032F |
6.2.5 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Tablet, 2022 - 2032F |
6.3 Belgium Follicle-Stimulating Hormone Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Fertility Treatment, 2022 - 2032F |
6.3.3 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By IVF Procedures, 2022 - 2032F |
6.3.4 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Ovulation Induction, 2022 - 2032F |
6.3.5 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Hormone Replacement Therapy, 2022 - 2032F |
6.4 Belgium Follicle-Stimulating Hormone Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Fertility Clinics, 2022 - 2032F |
6.4.4 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Gynecology Centers, 2022 - 2032F |
6.4.5 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.5 Belgium Follicle-Stimulating Hormone Market, By Dosage |
6.5.1 Overview and Analysis |
6.5.2 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By 75 IU-150 IU, 2022 - 2032F |
6.5.3 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By 225 IU-450 IU, 2022 - 2032F |
6.5.4 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By 50 IU-100 IU, 2022 - 2032F |
6.5.5 Belgium Follicle-Stimulating Hormone Market Revenues & Volume, By 10 mg-50 mg, 2022 - 2032F |
7 Belgium Follicle-Stimulating Hormone Market Import-Export Trade Statistics |
7.1 Belgium Follicle-Stimulating Hormone Market Export to Major Countries |
7.2 Belgium Follicle-Stimulating Hormone Market Imports from Major Countries |
8 Belgium Follicle-Stimulating Hormone Market Key Performance Indicators |
8.1 Number of fertility clinics offering follicle-stimulating hormone treatments in Belgium |
8.2 Adoption rate of advanced reproductive technologies in the country |
8.3 Average age of women seeking fertility treatments in Belgium |
8.4 Success rates of follicle-stimulating hormone treatments in improving fertility |
8.5 Number of research studies and clinical trials related to reproductive medicine in Belgium |
9 Belgium Follicle-Stimulating Hormone Market - Opportunity Assessment |
9.1 Belgium Follicle-Stimulating Hormone Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Belgium Follicle-Stimulating Hormone Market Opportunity Assessment, By Form, 2022 & 2032F |
9.3 Belgium Follicle-Stimulating Hormone Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Belgium Follicle-Stimulating Hormone Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Belgium Follicle-Stimulating Hormone Market Opportunity Assessment, By Dosage, 2022 & 2032F |
10 Belgium Follicle-Stimulating Hormone Market - Competitive Landscape |
10.1 Belgium Follicle-Stimulating Hormone Market Revenue Share, By Companies, 2025 |
10.2 Belgium Follicle-Stimulating Hormone Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here